Last update:

Medical economics news

Obstetrics & gynaecology

Racial disparities seen for insurance coverage around time of pregnancy

(HealthDay)—Disruptions in insurance coverage around the time of pregnancy disproportionately affect indigenous, Hispanic, and black non-Hispanic women, according to a study published in the April issue of Obstetrics & ...

Health

The answer to Indigenous vulnerability to coronavirus: Equitable public health

Among the latest coronavirus advice from the prime minister was an age-based self-isolation strategy designed to protect those considered most vulnerable in the global health crisis.

Diseases, Conditions, Syndromes

How COVID-19 could impact the most vulnerable in L.A. County

The COVID-19 pandemic may disproportionately impact the most vulnerable communities in Los Angeles County, reveals analysis by the Program for Environmental and Regional Equity (PERE) at USC Dornsife College of Letters, Arts ...

Medical economics

Female physicians drive unfunded research on pay disparity

Physician gender pay gaps continue to persist in the U.S. despite an impressive body of research spanning more than 25 years. While men have a larger representation within academic medical leadership, a new study publish ...

Medications

Improving competition and reducing costs of bio-pharmaceuticals

Georgia State Law associate professor Yaniv Heled focuses his career on the intersection of biotechnology and the law. For nearly a decade, he has dedicated much of his research to the regulation of bio-pharmaceuticals (also ...

Medical economics

National health spending expected to increase through 2028

(HealthDay)—National health expenditures are projected to increase at an average annual rate of 5.4 percent for 2019 to 2028, representing almost 20 percent of U.S. gross domestic product by 2028, according to a study published ...

Medications

FDA: Insulin among drugs transitioned to biological products

Insulin and other biologic drugs, such as human growth hormone, have now transitioned to being regulated as biological products, providing a new pathway for approval of biosimilars and interchangeable versions of these products ...

Diseases, Conditions, Syndromes

Will inequality worsen the toll of the pandemic in the U.S.?

A Harvard public health professor warned Tuesday that the COVID-19 outbreak in the U.S. could rank among the world's worst if the nation fails to take steps to ease the health and economic impacts on America's poor, who face ...